My research focuses on tumor immunology, chimeric antigen receptor (CAR) T-cell therapy, and combination immunotherapy for solid tumors. Over the years, our research has yielded mechanistic data that has been translated to CAR T-cell and combination immunotherapy clinical trials for patients with lung cancer, mesothelioma, and breast cancer. Our laboratory research has been funded by >70 grant awards resulting in >200 publications. In addition to serving on medical journal editorial boards, I am the Deputy Editor for Molecular Therapy Oncolytics.